Innovation Through Collaboration
2023 iC³ Sessions
Thursday, September 28, 2023: 7:30am - 6:30pm
Friday, September 29, 2023: 8:00am - 3:30pm
Irving Convention Center at Las Colinas
Resilience: The State of Biotech in Texas
Texas is well known for its determination and independence. What is not well known is that Texans are collaborative and are working together to make a difference in the bioscience industry in the Lone Star State.
Hear from Ernst & Young when they present the Texas version of their global Beyond Borders – Biotechnology Report. With insights into capital allocation strategies, investor perspectives, financial performance, and other key topics, the EY yearly analysis of the state of our industry helps global biotech leaders forge a path towards operational resilience and long-term value creation.
-
Sid Backstrom, JD
Chief Administrative Officer
G-CON Manufacturing
-
Eva Hevron
Partner
Ernst & Young
-
Anil Kumar, PhD, MS
Economic Policy Advisor and Senior Economist
Federal Reserve Bank of Dallas
-
Larry McManus
Director of Business and Community Development
Office of Texas Governor Greg Abbott
-
Todd Skrinar, MBA
Principal, US-West Health Sciences & Wellness Market Segment Leader
Ernst & Young
Cell & Gene Therapy – Wild West and the Next Frontier
Hear from experts provide the brief primer of history, advances, and implications of CGT in the USA, highlight CGT pioneers in Texas and discuss how we are advancing the industry here in this region.
-
Tania Martin-Mercado, PhD, MS, MPH
President & CEO, Chief Scientist
Phronetik
-
Berge Minassian, MD
Division Chief of Pediatric Neurology
UT Southwestern Medical Center
-
Vincent Shier, PhD
Partner
Haynes and Boone
-
Michael Stewart, PhD
COO
Matica Biotechnology
Texas as a Collaborative, Diverse Bioscience Ecosystem
Texas has become a haven for bioscience research and technology by taking a holistic approach and creating a collaborative, accessible ecosystem for innovation to thrive.
Learn from industry executives and institutional research leaders exactly how and why, the future is bright in North Texas.
-
Jenny Ligon
Senior Associate Director
National Center for Therapeutics Manufacturing
-
Komel Grover, MBA
President & CEO
Swiss American CDMO
-
Rupa Iyer, PhD
Vice President of Research, Innovation and Economic Development
Tarleton State University
-
Jason Mastoris
Co-Founder
Panthera Biosolutions
Insights for Addressing Pharma-Logistics Supply Chain Challenges
Often overlooked, but critical to the success of maintaining product integrity across the end-to-end supply chain.
Hear from industry supply chain leaders on how to avoid common pitfalls, mitigate risk, and build supply chain resilience.
-
Milton De La Paz
Vice President of Airlines Relations & Cargo Business
DFW International Airport
-
Greg Malter
District Manager
Expeditors
-
Brian Hodges
Director of Customer Insights, Products & Engagement
American Airlines
-
Steve Vondra
Vice President of Operations & Sales
SCL Cold Chain, LLC
-
Victoria Wilmore
Global Temperature Control Support Center Director
Johnson & Johnson
Begin with the End in Mind
The path to funding is rarely easy for an early-stage life science company. Implementing key practices early on can help you prepare for the future and identify issues that may create problems later.
Understanding which key milestones investors seek can help you know when to engage and how to prepare in advance. Learn what sets companies apart and how to put your best foot forward.
-
Milad Alucozai, MSc, MPH, DrPH
Head of Bio and Deep Tech
BoxOne Ventures
-
James Byrd, MS
Partner and IPO Readiness Leader
Deloitte
-
Michael Carr, MBA
Former President and CEO
Calyxt
-
Bonnie Jarecke
Partner
Deloitte
-
Courtney Tygesson, JD
Partner
Cooley
Commercial Launch Success Stories From the Four Corners of Texas
Executive leaders from life sciences will speak on different stages of the drug launch life cycle, and discuss challenges, opportunities, and futures to provide perspective for other companies embarking on the same journey.
Hear tangible examples of successes, pitfalls-and how to avoid them, as well as personal stories from commercial launches.
-
Dave Lowrance
CFO
Savara, Inc.
-
Michael Marquez
CFO
Nanoscope Therapeutics
-
Zachary Nelson, MBA
Texas Life Sciences Consulting Leader
RSM US LLP
-
Joe Payne
Vice President of Quality and Regulatory Affairs
Scorpius Biomanufacturing
-
Anthony Placencio
Partner
RMSM US LLP
-
Greg Salcido, MPA
CFO
Arugula Sciences
Investing Strategies and Trends in the MedTech Industry
Listen to a powerhouse panel of investors who share their perspectives on how the current market dynamics and trends are influencing med device growth in North Texas.
-
Gwen Watanabe, MBA, MS
Managing Director
H.I.G. Capital
-
Carter Meyer, JD
Founder & Managing Partner
View Ventures
-
Jonathan Norris, JD
Managing Director
HSBC Innovative Banking
-
Chad Ronholdt, MBA
Managing Director
NVB Ventures
Roadmap to Innovation: Hot Topics in Regulatory, Quality and Data Protection
Meeting the expectations of regulators during product development and commercialization is the key driver of the biotech industry. Our regulatory, quality, and data protection experts will be discussing some of today’s hottest topics.
-
Cheryl Beal Anderson, PharmD, MBA
Chief Executive & Founder
ACE Regulatory Affairs Consulting
-
Bobbi Drais, MS, RAC
President / Principal Consultant
Drais Regulatory Consulting, LLC
-
Julie Liambotis
US Director and Data Protection Manager
MyData-TRUST
-
Massoud Motamed, PhD
Vice President of Quality
Nanoscope Therapeutics
-
Trey Putnam, PhD, RAC
Vice President of Regulatory Affairs and Quality
Osteal Therapeutics
Development of a Cell & Gene Therapy Ecosystem in North Texas Fireside Chat
A successful biotech ecosystem requires solid, broad-reaching foundational research, strength through intellectual property, targeted commercial development, establishing manufacturing capabilities, corporate partnerships, and capital investment.
In this chat, we will discuss the keys to building an effective ecosystem in North Texas.
-
Adrian Denvir, PhD
Director of SBIR Programming
UNT Health Science Center
-
Gerry Farrell, PhD
Chief Operating Officer
Fujifilm Diosynth Biotechnologies
-
Vincent Shier, PhD
Partner
Haynes and Boone
The Physical Space of Biopharma Manufacturing
Biopharma is the intersection of biotechnology and pharmaceutical manufacturing. This panel will discuss the physical spaces required to bring these revolutionary technologies, including cell and gene therapy, to the public.
-
Patricia Larrabee, MS
President
Facility Logix
-
Thomas Page, PhD
Senior Vice President of Operational and Technology Alignment
FujiFilm Diosynth Biotechnologies
-
Joe Payne
Vice President of Quality and Regulatory Affairs
Scorpius Biomanufacturing
-
Bill Poole
Regional Director of Business Development
EwingCole / ECBuild
Resources for Startups
Starting a Bio/Health/Med Tech company can be hard, but you don’t have to do it alone! North Texas is full of fantastic resources for new and seasoned entrepreneurs.
In this panel, you will hear from local industry experts as we dive into topics including funding, business fundamentals, IP strategy, and risk management.
-
Adrian Denvir, PhD
Director of SBIR Programming
UNT Health Science Center
-
Gabby Everett, PhD
Director of Business Operations & Strategy, Site Head
BioLabs Pegasus Park
-
Kristin Lonergan, CIC
Market President, DFW
Cadence Insurance
-
Edward Meagher, JD
Partner
Carter DeLuca & Farrell LLP
-
Tiffanie Tovar
Senior Community Manager
MassChallenge
Rising Stars
Rising Stars are the next generation leaders tackling the biggest challenges in healthcare and life sciences exhibiting recent noteworthy achievements.
Listen to these North Texas based companies in the life science and healthcare innovation industry who are making a big impact in the community.
The Value of Having a Strategic Investor or Partner on Your Team
Having an investor or partner with knowledge and experience in your particular market can provide your company with a competitive advantage, reducing risks, and accelerating your growth.
Their insights, relationship connections, and expertise can be instrumental in achieving long-term success.
-
Cyonna Holmes, PhD
Global Strategy Leader Pharmaceutical Solutions Ophthalmology,
Rare Diseases, RNA
Celanese
-
Allison Rhines, MBA, PhD
Head of JLABS @ TMC
Johnson & Johnson Innovation
-
Erik Ringberg, MBA
Healthcare Distribution and Diagnostics Executive – VP/GM Lab
McKesson
-
Margaret Sampson, PhD, JD
Partner
McDermott Will & Emery
-
April Stanley, MS, MBA
Life Sciences Associate
Echo Investment Capital
How and Where is AI Impacting the Biopharma Industry?
AI and Machine Learning are a part of our economy. Join us and hear Key Opinion Leaders discuss the future of AI and its impact on the Biopharma Industry - facilitating and accelerated innovation and precision in medicine.
-
Claire Aldridge, PhD
Chief Strategy Officer
Form Bio
-
David Gascoigne
CEO
Almaden Genomics
-
Josh Seidenfeld, JD, MBA
Chair of Digital Health Practice
Cooley
-
Panna Sharma
President & CEO
Lantern Pharma
-
Gabriela Wilson, PhD, FHIMSS, SNAI, FIAHSI
Director of Health & Public Health Informatics
The University of Texas at Arlington
A Blunt Conversation About the Cost of Conversions
North Texas is ripe with spec warehouses, office space, and land for development, but there are many “costs” to consider when deciding on a location for your life science facility.
Panelists will discuss financial considerations, the cost of time in the race to market, environmental costs, tradeoffs, lessons learned, and more.
-
Ken Anthony, MS
Vice President of Life Science
Haskell
-
Jeremy Kinsel
Director of Preconstruction
BE&K Building Group
-
Hardik Patel
Co-Founder
Panthera Biosolutions
-
Chelsea Story
Vice President. Occupier Advisory & Transaction Services
CBRE
Tech Transfer Office Showcase and Pitch Competition
Listen to academic institutions across Texas showcase their best technologies that are available for licensing, collaboration and/or acquisition.
-
Hayden Blackburn
Executive Director
TechFW
-
Tricia D'Cruz
Founder & Managing Director
Catalyze Dallas
-
Nasreen Jacobson, PhD, MS
President/Owner
Kenatha Scientific Consulting, LLC
-
Allison Rhines, MBA, PhD
Head of JLABS @ TMC
Johnson & Johnson Innovation
-
Chad Ronholdt, MBA
Managing Director
NVB Ventures
-
Supriya Sinha, MS, PhD
Assistant Director, Commercialization Relations
UT Southwestern Medical Center
Innovation and the Future of Med Device in North Texas
Come listen to what the future of medical devices looks like from different perspectives; you’ll hear about how advancements in 3D printing of implants can lower healthcare costs and how biologics are merging with devices and transforming clinical outcomes.
-
Robert Bearden, PhD
Director of Research, Technology and Innovation
Smith & Nephew
-
John Davidson
President
Acuity Surgical
-
Steve Guengerich, MBA
Associate Vice President, Innovation & Commercialization
The University of Texas at Dallas
-
Gregory Howison, JD
Partner
Munck Wilson Mandala